Analysts have been eager to weigh in on the Healthcare sector with new ratings on Anavex Life Sciences (AVXL – Research Report) and Biohaven Pharmaceutical Holding Co (BHVN – Research Report). Anavex Life Sciences (AVXL) JonesTrading analyst Soumit Roy reiterated a Buy rating on Anavex Life Sciences today and set a price target of $40.00. The company's shares closed last Tuesday at $7.69, close to its 52-week low of $7.29. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-anavex-life-sciences-avxl-and-biohaven-pharmaceutical-holding-co-bhvn?utm_source=advfn.com&utm_medium=referral
Biohaven Pharmaceutical (NYSE:BHVN)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Biohaven Pharmaceutical Charts.
Biohaven Pharmaceutical (NYSE:BHVN)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Biohaven Pharmaceutical Charts.